Identifying genes for establishing a multigenic test for hepatocellular carcinoma surveillance in hepatitis C virus-positive cirrhotic patients

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 11, 2009, Pages 2929-2932

  Archer, Kellie J ^a,b   Mas, Valeria R ^a,c   David, Krystle ^c   Maluf, Daniel G ^c   Bornstein, Karen ^c   Fisher, Robert A ^c  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; EARLY GROWTH RESPONSE FACTOR 1; MOLECULAR MARKER; SYNAPTOBREVIN 2;

ARTICLE; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; ECHOGRAPHY; GENE EXPRESSION; GENETIC IDENTIFICATION; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CARCINOMA, HEPATOCELLULAR; FEMALE; GENE EXPRESSION PROFILING; HEPACIVIRUS; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 72749114315     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-09-0767     Document Type: Article

References (28)

1. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005;42:1208-1236
2. Llovet JM, Bruix J. Early diagnosis and treatment of hepatocellular carcinoma. Baillieres Best Pract Res Clin Gastroenterol 2000;14:991-1008. (Pubitemid 32094270)
3. Beale G, Chattopadhyay D, Gray J, et al. AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease. BMC Cancer 2008;8:200.
4. Yuen MF, Cheng CC, Lauder IJ, Lam SK, Ooi CG, Lai CL. Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology 2000;31:330-335
5. Nomura F, Ohnishi K, Tanabe Y. Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patients. Cancer 1989;64:1700-1707 (Pubitemid 19251142)
6. McCaughan GW, Koorey DJ, Strasser SI. Hepatocellular carcinoma: current approaches to diagnosis and management. Intern Med J 2002;32:394-400. (Pubitemid 36124653)
7. Irizarry RA, Hobbs B, Collin F, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003;4:249-264
8. Gui J, Li H. Penalized Cox regression analysis in the high-dimensional and low-sample size settings, witha pplications to microarray gene expression data. Bioinformatics 2005;21:3001-3008 (Pubitemid 40916425)
9. Ma S, Song X, Huang J. Supervised group Lasso withapplications to microarray data analysis. BMC Bioinformatics 2007;8:60. (Pubitemid 46443325)
10. Tibshirani R. The lasso method for variable selection in the Cox model. Stat Med 1997;16:385-395 (Pubitemid 27073009)
11. Archer KJ. Identifying important predictors using L1 penalized models and random forests. In JSM Proceedings. Alexandria (VA): American Statistical Association; 2009.
12. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing.
13. Gentleman RC, Carey VJ, Bates DM, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004;5:R80.
14. Park MY, Hastie T. L1-regularized pathalgorith m for generalized linear models. J Roy Stat Soc B Stat Meth2007;69:659-677
15. Yuan JS, Reed A, Chen F, Stewart CN, Jr. Statistical analysis of realtime PCR data. BMC Bioinformatics 2006;7:85.
16. Wurmbach E, Chen YB, Khitrov G, et al. Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma. Hepatology 2007;45:938-947 (Pubitemid 46646500)
17. Gautier L, Cope L, Bolstad BM, Irizarry RA. affy-analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 2004;20:307-315 (Pubitemid 38262761)
18. Huber W, Gentleman R. matchprobes: a Bioconductor package for the sequence-matching of microarray probe elements. Bioinformatics 2004;20:1651-1652 (Pubitemid 39023174)
19. Pepe MS, Etzioni R, Feng Z, et al. Phases of biomarker development for early detection of cancer. J Natl Cancer Inst 2001;93:1054-1061 (Pubitemid 32717537)
20. Grabowski P, Schonfelder J, Ahnert-Hilger G, et al. Expression of neuroendocrine markers: a signature of human undifferentiated carcinoma of the colon and rectum. Virchows Arch 2002;441:256-263
21. Roesch A, Wittschier S, Becker B, Landthaler M, Vogt T. Loss of dipeptidyl peptidase IV immunostaining discriminates malignant melanomas from deep penetrating nevi. Mod Pathol 2006;19:1378-1385 (Pubitemid 44423086)
22. Li R, Wang H, Bekele BN, et al. Identification of putative oncogenes in lung adenocarcinoma by a comprehensive functional genomic approach. Oncogene 2006;25:2628-2635
23. Iwasa K, Komai K, Yasukawa Y, Maruta T, Takamori M. [Molecular immunology of voltage-gated calcium channel and Lambert-Eaton myasthenic syndrome]. Nippon Rinsho 1997;55:3322-3330
24. Lee SH, Bahn JH, Choi CK, et al. ESE-1/EGR-1 pathway plays a role in tolfenamic acid-induced apoptosis in colorectal cancer cells. Mol Cancer Ther 2008;7:3739-3750
25. Hosmer DW, Lemeshow S. Applied logistic regression. New York: John Wiley & Sons; 1989.
26. Simon R. Development and validation of therapeutically relevant multi-gene biomarker classifiers. J Natl Cancer Inst 2005;97:866-867 (Pubitemid 41417930)
27. Stravitz RT, Heuman DM, Chand N, et al. Surveillance for hepatocellular carcinoma in patients withci rrhosis improves outcome. Am J Med 2008;121:119-126 (Pubitemid 351199465)
28. Bruix J, Llovet JM. Hepatocellular carcinoma: is surveillance cost effective? Gut 2001;48:149-150